Low Dose Aspirin Therapy – Should You Take It

Member Access Required

Join Now

Already a member? Sign In

Timeline

00:00

This is called low dose aspirin therapy. Should you take it?

00:57

drugs certainly in the class, but it's it's own class by itself it the mechanism of action inhibits the production of prostate gland in so that's how it works. It has anti-inflammatory properties and it has very unique anti-platelet properties.

01:53

hemorrhagic. You see that's bleeding stroke.

02:48

tell you the people that are risk are definitely not the young ones right before peptic ulcer disease and if you had a stroke and you're in your 40s or something and hemorrhagic stroke and you're on this medicine, this is going to be a massive medical error, you know and rare but people just get out there and they take it themselves. It's over the counter.

03:41

anti-coagulation medicines for dbts pulmonary embolisms. If you had a heart attack and you have stents bypass surgery, you're going to be on all these different meds.

04:37

unless there's some concert indication you're going to be on aspirin with other medicines, but if you don't have heart disease, but if you have significant plaque in the artery, you would need you would do well. Because you have heart disease just nothing's happened yet knocking on wood.

05:33

diabetes pre-diabetes all this kind of stuff. You may actually benefit from an aspen, but you want to know the risks come to the meeting with me.

06:29

cancer is up on the big three of cancers in the country that we have. You can do the research on that.

Video Summary

The video discusses low dose aspirin therapy and its historical role in prevention. It explains that aspirin affects platelet function and clot formation. The transcript highlights why aspirin was widely recommended in the past. It discusses evolving evidence regarding benefit versus risk. The speaker frames aspirin use as context dependent. This opening section establishes the clinical question.

The transcript explains bleeding risk associated with aspirin use. It discusses gastrointestinal and intracranial bleeding considerations. The video emphasizes differences between primary and secondary prevention. It highlights that cardiovascular benefit varies by individual risk. The speaker cautions against universal aspirin use. This section reinforces individualized assessment.

When guidance is discussed, the video emphasizes reviewing personal risk factors. It explains that age and cardiovascular history influence decisions. The transcript highlights the importance of clinician oversight. It discusses reassessing aspirin use over time. The closing message emphasizes informed decision making. Overall, the video frames aspirin therapy as selective.

Drug Callouts

Aspirin

Aspirin is an antiplatelet medication that inhibits platelet aggregation. In the transcript, low dose aspirin is discussed in relation to cardiovascular prevention and bleeding risk.

Condition Callouts

Cardiovascular disease

Cardiovascular disease refers to disorders involving the heart and blood vessels. In the transcript, aspirin use is discussed for cardiovascular risk reduction.

Gastrointestinal bleeding

Gastrointestinal bleeding is a medical condition involving bleeding within the digestive tract. In the transcript, gastrointestinal bleeding is discussed as a potential risk of aspirin therapy.

Key Takeaways

Aspirin inhibits platelet aggregation and affects clot formation.
Bleeding risk must be weighed against cardiovascular benefit.
Primary and secondary prevention differ in aspirin usefulness.
Individual cardiovascular risk determines potential benefit.
Aspirin therapy should be reassessed periodically.